Search





Search





Markets
/
Stocks
/
ikt
/

Inhibikase Therapeutics Inc

IKT

Add to Watchlist

2.330USD

+0.160+7.37%

Close 07-23 16:00（ET）Quotes delayed by 15 min

307.64MMarket Cap

LossP/E TTM

Inhibikase Therapeutics Inc

2.330

+0.160+7.37%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-23

Previous score

7.00

Change

The current institutional shareholding score of Inhibikase Therapeutics Inc is 7.00, ranking 80 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.17%, representing a quarter-over-quarter increase of 46.41%. The largest institutional shareholder is Frank Sands, holding a total of 12.86M shares, representing 7.64% of shares outstanding, with 36.96% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Sands Capital Ventures LLC

13.02M

Soleus Capital Management, L.P.

10.88M

+71.94%

Fairmount Funds Management LLC

8.63M

+40.82%

Adar1 Capital Management LLC

8.06M

+53.67%

Trails Edge Capital Partners LP

6.18M

Blackstone Alternative Asset Management, L.P.

5.94M

+125.08%

Invus Public Equities Advisors, LLC

5.85M

SP IKT Holdings LLC

5.84M

Perceptive Advisors LLC

5.42M

Commodore Capital LP

5.40M